Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years

Diabetes Care

Volumn 22, Issue 1, 1999, Pages 50-55

  Bruno, Graziella ^a,e   Trovati, Mariella ^c   De Salvia, Alberto ^a   Veglio, Massimo ^d   Arcari, Rosanna ^a   Pagano, Gianfranco ^a   Borra, Milena ^a   Grosso, Nadia ^a   Carta, Quirico ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d MAURIZIANO HOSPITAL   (Italy)

^e Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCAGON; GLUCOSE; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; PANCREAS ISLET CELL ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH;

ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; COHORT STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INCIDENCE; ISLETS OF LANGERHANS; ITALY; MALE; MIDDLE AGED; THINNESS;

EID: 0344026286     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.1.50     Document Type: Article

References (36)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
2. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727).
3. Kuzuda T, Matsuda A: Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes Care 20:219-220, 1997
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Commitee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
5. Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241, 1986
6. Anonymous: Insulin-dependent? Lancet ii:809-810, 1985
7. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Cohen M, Lang DA: Latent autoimmune diabetes in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
8. Leslie RDG, Pozzilli P: Type 1 diabetes masquerading as type 2 diabetes. Diabetes Care 17:1214-1219, 1994
9. Seibler J, Hering B, Richter W, Gluck M, Yassin N, Bretzel RG, Boehm BO, Federlin K, Scherbaum WA: Antibodies to the M, 64,000 (64K) protein in islet cell antibody-positive nondiabetic individuals indicate high risk for impaired β-cell function. Diabetologia 35:550-554, 1992
10. Kobayashi T, Tamemoto K, Nakamshi K, Kato K, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K: Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788, 1993
11. Rowley M, Mackay IR, Chen Q-Y, Knowles WJ, Zimmett PZ: Antibodies to glutamic acid decarboxylase discriminate major type of diabetes mellitus. Diabetes 41:548-551, 1992
12. Landin-Olsson M, Nilsson K-O, Lenmark A, Sundkvist G: Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 35:561-568, 1990
13. Tuomi T, Groop LC, Zimmett PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes 42:359-362, 1993
14. Zimmett PZ, Shaten BJ, Kuller LH, Rowley MJ, Knowles WJ, Mackay IR, for the MRFIT Research Group: Antibodies to glutamic acid decarboxylase and diabetes mellitus in the multiple risk factor intervention trial. Am J Epidemiol 140:683-690, 1994
15. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ: GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 12:1557-1565, 1995
16. Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G: β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type 2 diabetic patients. Diabetes Care 16:902-910, 1993
17. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay JR, Shattock M, Bottarzo GF, Holman R, for the UKPDS Study Group: UKPDS 25: antibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997
18. Ruige JB, Batstra MB, Aanstoot H-J, Bouter LM, Bruining GJ, de Neeling JND, Heine RJ: Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. Diabetes Care 20:1108-1110, 1997
19. Willis JA, Scott RS, Brown LJ, Forbes LV, Schmidli RS, Zimmett PZ, MacKay IR, Rowley MJ: Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. Diabetes Res Clin Pract 33:89-97, 1996
20. Humprey ARG, McCarty DJ, Mackay IR, Rowley MJ, Dwyer T, Zimmett P: Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus. Diabet Med 15:113-119, 1998
21. Wrobleski M, Gottsater A, Lindgarde F, Fernlund P, Sundkvist G: Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years. Diabetes Care 21:250-255, 1997
22. Thai AC, Ng WY, Loke KY, Lee WRW, Lui KF, Chean JS: Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia 40:1425-1430, 1997
23. Bruno G, Merletti F, De Salvia A, Lezo A, Arcari R, Pagano G, the Piedmont Study Group for Diabetes Epidemiology: Comparison of insulin-dependent diabetes mellitus in children and young adults in the province of Turin, Italy, 1984-91. Diabet Med 14:964-969, 1997
24. Schmidli RS, Colman PG, Bonifacio E, Participating Laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the Second International GADAb Workshop. Diabetes 44:636-640, 1995
25. Morel P, Dorman J, Todd J, McDevitt HO, Trucco M: Aspartic acid at position 57 of the HLA-DQ β-chain protects against type 1 diabetes: a family study Proc Natl Acad Sci USA 85:8111-8115, 1988
26. Gutierrez-Lopez MD, Bertera S, Chantres MT, Vavassori C, Dorman J, Trucco M, Serrano-Rios M: Susceptibility to type 1 diabetes in Spanish patients correlates qualitatively with expression of HLA-DQA Arg 52 and HLA-DQB non-Asp 57 alleles. Diabetologia 35:583-588, 1992
27. Hother-Nielsen O, Faber O, Sorensen NS, Beck-Nielsen H: Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 11:531-537, 1988
28. Garancini MP, Gobbi C, Errera A, Sergi A, Gallus G: Age-specific incidence and duration of known diabetes: the Cremona Study. Diabetes Care 19:1279-1282, 1996
29. Leslie RDG: Intervention in patients with type I diabetes masquerading as type II. Diabetes Nutr Metab 9:319-324, 1996.
30. The Diabetes Control and Complications Trial Research Group: Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial: a randomized, controlled trial. Ann Intern Med 128:517-523, 1998
31. Karjalainen J, Salmela P, Ilonen J, Surcel H-M, Knip M: A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881-586, 1989
32. Service FJ, Rizza RA, Zimmerman BR, Dyck PJ, O'Brien PJ, Melton LJ: The classification of diabetes by clinical and C-peptide criteria: a prospective population-based study Diabetes Care 20:198-201, 1997
33. Service FJ: New classification of diabetes (Letter). Diabetes Care 21:469, 1998
34. Vandewalle CL, Coeckelberhs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Diabetes Care 20:1556-1561, 1997
35. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG: IA-2 autoantibodies complement GAD65 autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99, 1997
36. Lohmann T, Seissler J, Verlohren H-J, Schroder S, Rotger J, Karsten D, Morgenthaler N, Scherbaum W: Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20:524-529, 1997